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Vascular calcification is a complex process that is dependent
not only on the physicochemical effects of Ca, PO4, and pH,
but also on smooth muscle factors that may be regulated by
these ions as well as by 1,25-dihydroxyvitamin D3 (calcitriol)
and parathyroid hormone (PTH). These minerals and
hormones were tested in a model of medial calcification in
rat aorta maintained in culture for 9 days. Calcification was
quantitated as incorporation of 45Ca, alkaline phosphatase
activity was measured in aortic homogenates, and
osteopontin production was measured from immunoblots of
culture medium. At 1.8 mM Ca (1.46 mM free), calcification
occurred at or above 2.8 mM PO4. At 3.8 mM PO4, calcification
occurred at or above 1.10 mM free [Ca]. At a constant
[Ca] [PO4], calcification varied directly with [Ca] and
inversely with [PO4]. Calcification was directly related to pH
between 7.19 and 7.50 but not altered by PTH or calcitriol.
Alkaline phosphatase activity and osteopontin production
were increased by Ca, PO4, calcitriol, and PTH. We conclude
that calcification of rat aorta in vitro requires elevation of
both [Ca] and [PO4], and that [Ca] rather than [PO4] or the
product of the two is the dominant determinant. The
induction of alkaline phosphatase and osteopontin indicates
that Ca and PO4 have effects in addition to simple
physicochemical actions. Although PTH and calcitriol did not
increase calcification in vivo, they have effects on smooth
muscle that could influence calcification in vivo. Calcification
is enhanced by alkalinity within the range produced during
hemodialysis.
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Vascular calcification is extremely common in patients with
advanced renal failure or end-stage renal disease,1 and may
contribute to their elevated risk of cardiovascular disease.
Although calcification can be associated with atherosclerosis
in these patients, the deposition of hydroxyapatite is
primarily medial rather than intimal, and is not associated
with inflammation.2,3 The pathophysiology of medial
calcification is complex, involving not only physicochemical
factors but also biologic actions in smooth muscle.
Physicochemical considerations are the basis for the clinical
use of the calcium–phosphorus product (Ca P). Although
the serum Ca P is associated with soft tissue calcification,4
coronary artery calcification,1 and cardiovascular mortality5
in hemodialysis patients, there are no data showing a
causative role in vascular calcification. The principal biologic
effect of smooth muscle is the production of inhibitors of
calcification. Humans lacking an enzyme that produces
extracellular pyrophosphate, a known inhibitor of hydro-
xyapatite formation,6–8 develop severe medial vascular
calcification in childhood,9,10 indicating that calcification
can occur at normal calcium and phosphate levels in the
absence of inhibition. We have recently confirmed the
inhibitory role of smooth muscle pyrophosphate in rat
aortas in vitro.11 Protein inhibitors have been described as
well. Mice lacking matrix Gla protein and rats treated with
warfarin to prevent its g-carboxylation develop severe medial
calcification,12,13 although humans lacking this protein
(Keutel syndrome) do not develop prominent calcification.14
Mice deficient in osteoprotegerin also develop medial
calcification,15 and osteopontin inhibits calcification in
cultured smooth muscle cells.16,17 Although deficiency of
osteopontin does not lead to vascular calcification in mice, it
does worsen calcification in mice lacking matrix Gla
protein.18 An additional biologic action that may promote
calcification is osteogenic differentiation of smooth muscle.19
Recent data suggest that biologic effects of smooth muscle
on calcification may be governed by systemic mineral
metabolism. In cultured vascular smooth muscle cells, both
Ca and PO4 increase alkaline phosphatase activity (which
hydrolyzes pyrophosphate) and osteopontin production,16,20
and phosphate induces osteoblastic differentiation factors
such as osteocalcin and Cbfa-1.21 High doses of vitamin D3
induce medial vascular calcification in rats,22 and calcitriol
enhances calcium deposition in cultured smooth muscle
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cells.23 Parathyroid hormone (PTH) at high concentrations
inhibits calcification of vascular smooth muscle cells in
culture.24
In vitro studies of vascular calcification have been
performed almost exclusively in cultured smooth muscle
cells, but this model is limited by the substantial phenotypic
changes these cells undergo in culture and the fact that they
lack elastin, the site of medial calcification in vivo.25 Thus,
it is not clear that these cells accurately reflect the patho-
physiology of medial vascular calcification and there are no
data showing a direct role for Ca, PO4, calcitriol, or PTH in
the calcification of intact vessels. To address this, we recently
developed an in vitro model of vascular calcification in rat
aortas during long-term culture under conditions that
maintain viability and normal histology and prevent
apoptosis.11 In the presence of high calcium and phosphate
concentrations along with alkaline phosphatase to remove
inhibitory pyrophosphate, medial deposits of hydroxyapatite
develop along elastic lamina in a pattern similar to that
observed in vessels from patients with chronic renal failure.11
Using this model, we examined the effect of Ca, PO4, pH,
calcitriol, and PTH on the rate of calcification and the
induction of proteins related to vascular calcification.
RESULTS
Figure 1 shows a von Kossa stain of an aortic ring cultured for
9 days in the presence of alkaline phosphatase and a high
phosphate concentration. This degree of calcification is
observed in cultured aortas when the calcium content is
roughly 500 nmol/mg dry weight or greater, and contents
below 50 nmol/mg are usually not visible on Von Kossa
staining. To determine the dependence of calcification on the
concentration of phosphate, incorporation of 45Ca was
measured at different phosphate concentrations with the
calcium concentration maintained constant at 1.8 mM, the
concentration normally present in Dulbecco’s modified
Eagle’s medium (DMEM) (Figure 2). There was a very small
incorporation of 45Ca into aortas cultured in 0.9 mM PO4,
the concentration normally present in DMEM. We have
previously shown that this incorporation occurs in the first
day and represents equilibration with Ca normally present in
the vessel wall.11 This incorporation began to increase when
[PO4] reached 2.7 mM and increased substantially thereafter.
The measured concentrations of ionized Ca at the lowest and
highest [PO4] were 1.46 and 1.21 mM. The dependence of
calcification on calcium concentration was assessed by
varying the concentration of calcium at a constant phosphate
concentration of 3.8 mM (Figure 3). Because the concentra-
tion of Ca is already high in DMEM, a medium similar to
DMEM was reformulated from components to yield a
reduced [Ca] of 1.33 mM. No calcification occurred at a
[Ca] of 1.33 or 1.49 mM but calcification increased substan-
tially starting at 1.65 mM (1.10 mM free [Ca]). Calcification
did not occur at physiologic concentrations of PO4 (0.9 mM)
or Ca (0.99 mM free) despite maximal concentrations of the
other ion. To determine whether the effects of Ca and PO4
were governed by the product of their concentrations, the
concentrations were varied inversely to maintain a constant
product of 6.84 mmol2/l2. As shown in Figure 4, calcification
varied directly with [Ca] and inversely with [PO4], with only
basal calcium incorporation at the highest [PO4] and lowest
[Ca] and extensive calcification at the highest [Ca] and
lowest [PO4].
Because vascular calcification in uremia may be dependent
on vessel injury and circulating factors other than Ca and
PO4, these experiments were repeated in the presence of
uremic plasma or after vessel injury. The same dependence
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Figure 1 | Calcification of rat aorta cultured for 9 days in DMEM
containing 3.8 mM PO4 and alkaline phosphatase. Von Kossa stain
shows dark staining of calcium phosphate in the media.
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Figure 2 | Effect of phosphate concentration on calcification of rat
aortas in culture. Calcium concentration was 1.8 mM. Values are the
means of 3–8 individual aortic segments. Error bars: s.e. *Po0.001 vs
0.9 mM phosphate.
500
400
300
200
100Ca
2+
 
de
po
sit
io
n
(nm
ol/
mg
)
0
1.2 1.4 1.6
*
*
[Ca] mM
1.8
Figure 3 | Effect of calcium concentration on calcification of rat
aortas in culture. Phosphate concentration was 3.8 mM. Values are
the means of 4–6 individual aortic segments. Error bars: s.e. *Po0.001
vs 1.33 mM calcium.
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on Ca rather than PO4 at a constant product was observed in
vessels cultured with 10% pooled, predialysis plasma from
hemodialysis patients (Figure 5), or in vessels that had been
frozen and thawed prior to culture (Figure 6). The threshold
[Ca] and [PO4] for calcification were 36 and 44% higher in
the presence of plasma or serum (not shown). This was due
in part to binding of Ca to protein since ionized Ca
concentrations were 15% lower.
In addition to Ca and PO4 concentrations, solubility of
hydroxyapatite is also dependent on pH. To determine
whether aortic calcification varied within the pH range that
occurs in vivo, the pH of the culture medium was varied from
7.2 to 7.5 (Figure 7). Calcification was reduced in acidic
medium and was substantially increased at pH 7.5. Greater
degrees of alkalinity could not be tested because of
precipitation of calcium from the medium. A phosphate
concentration of 2.8 mM was used in these studies to ensure
that an intermediate degree of calcification occurred at
normal pH (7.4). To determine whether intermittent periods
of alkalosis equivalent to those that occur during hemodia-
lysis could also increase calcification, pH of the medium was
increased from 7.4 to 7.5 for 5 h every other day. As shown in
the right-hand bars, calcification increased 2.5-fold compared
to medium changes performed at a constant pH of 7.4.
Calcium incorporation into rat aortas was not altered by
calcitriol or rat PTH 1–34 (Figure 8), each at a concentration
of 100 nM. Several concentrations of phosphate were used so
that either augmentation or inhibition of calcification could
be detected. To assess responsiveness to PTH, cyclic 30,50
adenosine monophosphate was measured in aortas before
and after exposure to PTH for 5 min. In fresh aortas, PTH
increased cyclic 30,50 adenosine monophosphate content
(normalized to wet weight) 77% from 5.8470.33 to
10.371.37 pmol/mg (Po0.01). Basal cAMP content was
lower after 9 days in culture (2.1570.08 pmol/mg), but still
responded to PTH with an increase of 53% to
3.2970.35 pmol/mg (Po0.05).
In addition to calcification, the induction of proteins
related to calcification was also investigated. Figure 9 shows
the activity of alkaline phosphatase in homogenates of aorta
after 9 days in culture without added alkaline phosphatase.
Activity was increased two- to three-fold when PO4, PTH, or
calcitriol were added to the medium. The effect of PTH and
PO4 were not additive (not shown). The effect of calcium was
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Figure 4 | Calcification at varying [Ca] and [PO4] with CaP kept
constant at 6.84 mmol2/l2. Values are the means of 7–15 individual
aortic segments. Error bars: s.e. *Po0.001 vs 1.33 mM calcium and
5.14 mM phosphate.
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Figure 5 | Calcification at varying [Ca] and [PO4] in the presence
of uremic plasma at a constant CaP. Plasma was obtained from
several hemodialysis patients just prior to dialysis, heat-inactivated at
561C for 1 h, and added to the cultures at a final concentration of
10%. Values are the means of seven individual aortic segments.
Ca P¼ 10.1 mmol2/l2. Error bars: s.e. *Po0.01, **Po0.001 vs highest
phosphate concentration.
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Figure 6 | Calcification of injured aortas at varying [Ca] and [PO4]
but constant CaP in the presence of 10% serum without added
alkaline phosphatase. Aortas were frozen and thawed five times
prior to culture. Left-hand bars: Ca P¼ 8.61 mmol2/l2. Right-hand
bars: Ca P¼ 9.35 mmol2/l2. Values are the means of four individual
aortic segments. Error bars: s.e. *Po0.003, **Po0.001 vs highest
phosphate concentration.
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Figure 7 | Effect of medium pH on calcification of rat aorta in
culture. Aortic segments were incubated in DMEM medium
containing 2.8 mM PO4 for 9 days at different pHs (constant, n¼ 6–8)
or for 9 days at pH 7.4 with a medium change to the indicated pH for
5 h every other day (intermittent, n¼ 15–18). Error bars: s.e.
*Po0.003, **Po0.01 vs pH of 7.4.
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studied separately since reformulated DMEM was used. An
increase in [Ca] from 1.3 mM back to 1.8 mM more than
tripled alkaline phosphatase activity. The reformulated
medium with 1.8 mM Ca yielded a higher alkaline phospha-
tase activity than commercially prepared DMEM with the
same Ca concentration. Osteopontin production, measured
by immunoblotting medium from the last 3 days of culture
(without added alkaline phosphatase), was also increased by
PO4, Ca, PTH, or calcitriol (Figure 10).
DISCUSSION
This is the first study to examine the effects of calcium,
phosphate, and relevant hormones on arterial calcification in
vitro. Although effects have been studied in smooth muscle
cells in culture,16,20,21 these cells undergo phenotypic changes
and lack a normal extracellular matrix including elastin, the
principal site of medial calcification in vivo.25 Since aortas
from small mammals do not contain vasa vasorum,26 they
rely entirely on diffusion for nutrition and thus are amenable
to culture. We have previously shown that aortic structure
and viability are maintained for at least 9 days in culture.11
Calcification of rat aorta in culture increased directly with the
concentration of calcium or phosphate, but at concentrations
greater than those commonly observed in vivo. In general,
calcification required PO4 concentrations of 2.8 mM or
greater and Ca concentrations of 1.8 mM (1.30 mM free Ca)
or greater. This is equivalent to a serum phosphorus
concentration in humans of 8.4 mg/dl and, based on the
assumption that 43% of the calcium in serum is ionized,27 a
serum Ca concentration of 12.6 mg/dl. The thresholds for
calcification were higher in the presence of serum or in
injured aortas but the patterns were unchanged.
To reflect the dual roles of PO4 and Ca, the product of the
two concentrations is often used clinically to assess the risk of
vascular calcification. However, the assumption that the two
ions affect calcification equally has never been tested. When
[Ca] and [PO4] were varied inversely to maintain a constant
product, calcification of rat aorta in culture varied substan-
tially, demonstrating that calcification is not a function of the
product but rather depends on the individual concentrations.
Of note, calcification varied directly with [Ca] despite a
decreasing [PO4]. The dominance of Ca is not unexpected
based on the stoichiometry of calcium phosphate. The same
dependence on [Ca] rather than [PO4] was observed in the
presence of plasma from patients with end-stage renal disease
and in injured vessels. While exposure to uremic plasma in
vitro does not necessarily mimic uremia, these results indicate
that the dependence of calcification on Ca and PO4 is not
altered by circulating factors.
The formation of hydroxyapatite is complex and cannot
be described by a simple solubility product.28 The initial
event appears to be formation of CaHPO4  2H2O (brushite),
which is not stable at physiologic pH but can be converted to
hydroxyapatite, the only stable form of calcium phosphate at
physiologic pH. Owing to the extremely low solubility of
hydroxyapatite, normal human serum is supersaturated with
respect to hydroxyapatite. However, hydroxyapatite is not
formed directly and derives instead from brushite, and the
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Figure 8 | Effect of PTH and calcitriol on calcification of rat aortas
in culture. Aortas were cultured for 9 days in DMEM or DMEM with
100 nM calcitriol or rat PTH(1–34). Fresh medium and calcitriol, or PTH
were added every 3 days. The number of aortic segments studied
were as follows: 0.9 mM PO4: three in each group; 2.8 mM PO4: 7–14 in
each group; 3.8 mM PO4: six in each group with alkaline phosphatase
and 15–17 in each group without alkaline phosphatase. Error bars: s.e.
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Figure 9 | Effect of Ca, PO4, PTH, and calcitriol on alkaline
phosphatase activity in rat aorta. Aortas were incubated in DMEM
medium without added alkaline phosphatase under the specified
conditions for 9 days and alkaline phosphatase activity was measured
in homogenates. Control DMEM contained 1.8 mM Ca and 0.9 mM PO4.
PTH or calcitriol were added at 100 nM. To test the effect of Ca, DMEM
was reformulated from components to contain 1.3 mM Ca and then
additional Ca was added to yield 1.8 mM. Each bar is the mean7s.e. of
eight aortic rings. *Po0.001 vs standard DMEM.
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Figure 10 | Effect of Ca, PO4, PTH, and calcitriol on osteopontin
production by rat aorta. Aortas were incubated in DMEM medium
without added alkaline phosphatase under the specified conditions
for 9 days. Medium was changed after 6 days and then collected at
the end of the culture for measurement of osteopontin by
immunoblotting. Control DMEM contained 1.8 mM Ca and 0.9 mM
PO4. PTH or calcitriol were added at 100 nM. To test the effect of Ca,
DMEM was reformulated from components to contain 1.3 mM Ca and
then additional Ca was added to yield 1.8 mM. Results are means7s.e.
of three separate experiments. *Po0.001.
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product of the activities of Ca2þ and HPO4
2 in human
serum and DMEM is less than the solubility constant for
brushite under physiologic conditions (2.2 107 M). All the
media with higher phosphate concentrations exceed this and
also exceed the precipitation point for brushite in simple salt
solution at pH 7.4, which is 50% greater. Despite this, no
spontaneous precipitation occurred, indicating that the
precipitation point is higher in DMEM. In media with
varying calcium and phosphate concentrations, aortic
calcification varied widely despite solubility products that
were very similar (8.5–8.6 107). Thus, medial vascular
calcification cannot be explained solely by solubility con-
siderations.
Our data also indicate that calcium and phosphate have
biologic effects on vascular smooth muscle that could
influence calcification in addition to physicochemical effects
on hydroxyapatite formation. In cultured aortas, both
alkaline phosphatase activity and osteopontin production
were increased by maximal concentrations of Ca or PO4,
which lends credence to similar findings in cultured vascular
smooth muscle cells.16,20 Since both proteins can be markers
of osteoblastic differentiation, this supports the finding that
phosphate induces osteoblastic differentiation factors such as
osteocalcin and Cbfa-1 in smooth muscle cells in culture.21
The relative dependence of vascular calcification on Ca and
PO4 and the absence of an effect of PTH or calcitriol
observed in vitro cannot be extrapolated to clinical practice
since the mechanism of vascular calcification in end-stage
renal disease is not established and is a slower process that
may not be entirely recreated in our culture system. We have
previously shown that calcification of aortas is apparent by 6
days in culture and increases rapidly thereafter.11 Since
calcification is a continuous process, the amount present at 9
days actually represents a rate rather than a fixed amount.
Thus, the absence of 42Ca after 9 days could also be due to a
very slow rate of calcification.
Calcification in vitro occurs only in the presence of
supranormal levels of alkaline phosphatase, necessary to
remove inhibitory pyrophosphate.11 Cultured smooth muscle
cells have a much higher alkaline phosphatase level than
intact vessels,16,11 but exogenous enxyme must be added to
rat aortas. The concentrations of Ca and PO4 required for
calcification in vitro are higher than the circulating levels in
most end-stage renal disease patients. Depending on which
ion was varied, the threshold Ca P for calcification in vitro
was equivalent to values of 102 to 122 mg2/dl2 in human
serum. It is possible that the high concentrations of calcium
and phosphate are necessary to overcome active inhibition of
calcification by vascular smooth muscle.11–17 Alternatively,
since calcification in vivo is a slower process, it could occur at
lower concentrations of Ca and PO4. Despite the limitations
of these in vitro data, they are the only data on vessel
calcification and the results suggest that further studies are
needed to determine whether the calcium–phosphorus
product is an appropriate parameter for gauging the risk of
vascular calcification in vivo.
The solubility of calcium phosphate is dependent on pH,
but the effect of pH on vascular calcification has not
previously been examined. The increased calcification of rat
aortas in alkaline medium may have important implications
because of the transient alkalemia during hemodialysis.
Typical dialysates contain 35–40 mM bicarbonate and result
in a blood pH of 7.50–7.52 after dialysis,29,30 which is equal to
or even greater than the degree of alkalinity shown to increase
calcification in cultured aortas (pH 7.5). Even transient
increases in medium pH akin to hemodialysis every other day
resulted in increased calcification, raising the possibility that
hemodialysis could actually worsen vascular calcification. The
fact that coronary artery calcification correlates very strongly
with the number of years of hemodialysis1 is consistent with
this, but could also be related to the duration of end-stage
renal disease or to other therapies such as calcium-based
phosphate binders.1,31 Transient alkalemia is avoided in
peritoneal dialysis, but whether this is associated with less
vascular calcification is unknown.
Although calcitriol has been reported to increase calcifica-
tion of smooth muscle cells in culture,23 calcitriol did not
affect calcification in intact aortas despite a concentration
that was 1000-fold greater than levels in human serum.27 The
fact that osteopontin was upregulated indicates that the
aortas were responding to calcitriol, which is consistent with
the known transcriptional regulation of osteopontin by
calcitriol in bone cells.32 Since high doses of vitamin D3
produce vascular calcification in rats,22 our results suggest
that this is not a direct effect of calcitriol on vascular smooth
muscle. We cannot rule out the possibility that calcitriol may
act synergistically with other factors in vivo. PTH also had no
effect on aortic calcification in culture despite the fact that
the smooth muscle remained responsive to PTH during
culture. This result in intact smooth muscle differs from the
inhibition by PTH of calcification in cultured vascular
smooth muscle cells.24 We cannot rule out the possibility
that longer periods of culture are required to observe effects
of calcitriol or PTH on calcification, but the duration of
treatment was longer than that for previous studies
demonstrating effects of these hormones on cultured smooth
muscle cells. The effects noted in cultured cells but not in
cultured aortas may be the result of a calcification process in
cultured cells that differs from medial calcification in intact
vessels.
The increase in aortic alkaline phosphatase activity and
osteopontin production observed with Ca, PO4, calcitriol,
and PTH may have important implications for vascular
calcification. Alkaline phosphatase hydrolyzes pyropho-
sphate, an important inhibitor of vascular calcification,11,10
and controls its level in vivo.33 Osteopontin, on the other
hand, is an inhibitor of calcification under certain conditions
when it is phosphorylated.17 However, this effect might
be nullified by the upregulation of alkaline phosphatase,
which dephosphorylates osteopontin. The upregulation of
these proteins cannot explain the calcification observed in
aortic culture since excess alkaline phosphatase was added.
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However, this upregulation could contribute to calcification
in vivo.
In summary, this study demonstrates that calcification of
rat aortas in vitro requires elevation of both Ca and PO4
concentrations, but is not strictly governed by the product of
the two. PTH and calcitriol do not directly affect calcification
but, along with Ca and PO4, have effects on osteopontin and
alkaline phosphatase that could affect calcification. Calcifica-
tion is also enhanced by alkalemia in the range observed after
hemodialysis.
MATERIALS AND METHODS
Aortic culture
Aortic culture was performed as previously described.11 Briefly,
aortas were removed under sterile conditions from male Sprague–-
Dawley rats weighing 150–250 g and most of the adventitia was
removed by careful dissection. Adventitia was not completely
removed as this led to smooth muscle injury. The vessels were cut
into 3–4 mm rings and placed in DMEM medium (Mediatech,
Herndon, VA, USA) without serum at 371C in a 5% CO2 incubator
with medium changes every 3 days. Unless otherwise specified, calf
intestinal alkaline phosphatase (Promega, Madison, WI, USA) was
added at a final concentration of 3.75 U/ml. DMEM medium with a
reduced [Ca] of 1.3 mM instead of 1.8 mM was made from
components (50 minimal essential medium amino acids, 100
minimal essential medium nonessential amino acids, and 100
minimal essential medium vitamins) purchased from Gibco-BRL
(Rockville, MD, USA). Medium pH was altered by adding HCl or
NaHCO3. Ionized concentrations of Ca and phosphate were
determined using CaBuffer software based on a [Mg] of 0.88 mM,
a [glycine] of 0.4 mM, an ionic strength of 0.3 M, and a pH of 7.4.
Measurements with an ion-selective probe gave ionized Ca values
that were 17% lower in standard medium and 26% lower in high-
phosphate medium, and the calculated values were corrected
accordingly. Activities of Ca2þ and HPO4
2 were calculated from
published activity coefficients,28 and the proportion of phosphate
present as HPO4
2 was assumed to be 81%.28 Measurement of tracer
45Ca was performed on all media before and after centrifugation to
ensure that all the calcium was soluble. Medium 45Ca was measured
at the end of culture periods to ensure that calcium levels were
maintained. Rat PTH 1–34 and 1,25-dihydroxyvitamin D3 (calci-
triol) were obtained from Sigma Chemicals (St Louis, MO, USA).
Quantification of calcification
Tracer 45Ca (0.5 mCi/ml) was added to the culture medium, and after
9 days the aortas were washed five times in physiologic saline.
Residual adventitia was then removed and the rings were dried,
weighed, and then dissolved in 15% H2O2 and 35% HClO4 for 2 h at
801C for quantification of radioactivity by liquid scintillation.
Quantification of osteopontin
Immunoblots were performed after separation of culture medium
on a 10% SDS polyacrylamide gel and blotting onto polyvinylidine
difluoride membranes, using a mouse monoclonal antibody
(MPIIIB101) created by M Solursh and A Franzen and obtained
from the Developmental Studies Hybridoma Bank developed under
the auspices of the NICHD and maintained by the University of
Iowa, Department of Biological Sciences (Iowa City, IA, USA). Rat
recombinant osteopontin was produced as a hexahistidine fusion
protein from cDNA kindly provided by Dr Magnus Hook (Institute
of Bioscience and Technology, Texas A&M University). Quantifica-
tion was by densitometry, using recombinant osteopontin as a
standard.
Alkaline phosphatase activity
Alkaline phosphatase was measured colorimetrically as the hydro-
lysis of p-nitrophenyl phosphate according to instructions from the
supplier (Sigma Diagnostics, St Louis, MO, USA). Aortas were
homogenized in radioimmunoprecipitation assay buffer (10 mM
Tris, pH 7.4; 2.5 mM EDTA; 50 mM NaF; 1 mM Na4P2O7  10H2O; 1%
Triton X-100; 10% glycerol; 1% deoxycholate, 1 mg/ml aprotinin,
0.18 mg/ml PMSF, 0.18 mg/ml orthovanadate, 1% Triton X-100 in
0.9% saline) on ice and centrifuged in a microfuge at maximum
speed for 5 min. Supernatant was removed for assay.
Cyclic AMP assay
Aortas were incubated with PTH for 5 min and then frozen in liquid
nitrogen. After grinding the aortas in 100 mM HCl at room
temperature, cyclic AMP was measured by an enzyme-linked
immunoassay (Assay Design Incorporated; Ann Arbor, MI, USA)
as described by the manufacturer.
Statistics
Data are presented as mean7s.e. Significance was tested by two-
tailed Student’s t-test. For multiple comparisons, the P-value was
multiplied by the number of comparisons. For skewed data, a
logarithmic transformation was applied prior to statistical analysis.
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